Saw Palmetto, Serenoa repens, in the Treatment of Benign Prostatic Hyperplasia, Mechanisms of Action and Reasons for its Use
Pharmacy & Pharmacology International Journal · 2014
DOI: 10.15406/ppij.2015.02.00007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy & Pharmacology International Journal, 2014. Verfasst von James Adams. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Saw palmetto, Serenoa repens, produces berries that are the source of a popular medicine used in the treatment of benign prostatic hyperplasia, prostate infections, prostatitis, chronic pelvic pain syndrome, prostate cancer, hypotonic neurogenic bladder, sexual dysfunction and other conditions.Several clinical trials have been conducted with various extracts of the plant.The results have been mixed.Metaanalyses and systematic reviews of the trials have concluded that S. Repens appears to be effective in the treatment of benign prostatic hyperplasia.The mechanism of action of the medicine is not clear.This review discusses the possibility that medium length fatty acids from S. Repens decrease the inflammation of the prostate by altering adipokine secretion from visceral fat.This leads to less hyperplasia and perhaps less risk of promoting prostate cancer.
Zitieren
APA
Adams, J. (2014). Saw Palmetto, Serenoa repens, in the Treatment of Benign Prostatic Hyperplasia, Mechanisms of Action and Reasons for its Use. Pharmacy & Pharmacology International Journal. https://doi.org/10.15406/ppij.2015.02.00007
Vancouver
Adams J. Saw Palmetto, Serenoa repens, in the Treatment of Benign Prostatic Hyperplasia, Mechanisms of Action and Reasons for its Use. Pharmacy & Pharmacology International Journal. 2014. doi:10.15406/ppij.2015.02.00007
BibTeX
@article{Adams2014,
author = {Adams, James},
title = {Saw Palmetto, Serenoa repens, in the Treatment of Benign Prostatic Hyperplasia, Mechanisms of Action and Reasons for its Use},
journal = {Pharmacy & Pharmacology International Journal},
year = {2014},
doi = {10.15406/ppij.2015.02.00007}
}
EUVIMED